The clustering of psychopathology among adults seeking treatment for alcohol and drug addiction

Journal of Substance Abuse Treatment

Volumn 49, Issue , 2015, Pages 21-26

  Urbanoski, Karen ^a,b   Kenaszchuk, Chris ^a   Veldhuizen, Scott ^a   Rush, Brian ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Comorbidity; Latent class analysis; Mental disorders; Multimorbidity

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; OPIATE;

ADULT; AGE; AGORAPHOBIA; ALCOHOLISM; ARTICLE; CRIMINAL JUSTICE; DRUG DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; MENTAL DISEASE; OUTPATIENT CARE; PSYCHOSIS; SEX DIFFERENCE; SOCIAL PHOBIA; SUBSTANCE ABUSE; ALCOHOL-RELATED DISORDERS; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PATIENT ATTITUDE; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS;

ADULT; ALCOHOL-RELATED DISORDERS; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PATIENT ACCEPTANCE OF HEALTH CARE; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS;

EID: 84920558516     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2014.07.004     Document Type: Article

References (45)

1. Adamson S.J., Todd F.C., Sellman J.D., Huriwai T., Porter J. Coexisting psychiatric disorders in a New Zealand outpatient alcohol and other drug clinical population. The Australian and New Zealand Journal of Psychiatry 2006, 40(2):164-170. 10.1111/j.1440-1614.2006.01764.x.
2. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974, AC-19(6):716-723.
3. Andrews G., Henderson S., Hall W. Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. British Journal of Psychiatry 2001, 178:145-153.
4. Baker K.D., Lubman D.I., Cosgrave E.M., Killackey E.J., Yuen H.P., Hides L., et al. Impact of co-occurring substance use on 6month outcomes for young people seeking mental health treatment. The Australian and New Zealand Journal of Psychiatry 2007, 41(11):896-902. 10.1080/00048670701634986.
5. Batstra L., Bos E.H., Neeleman J. Quantifying psychiatric comorbidity-Lessons from chronic disease epidemiology. Social Psychiatry and Psychiatric Epidemiology 2002, 37(3):105-111.
6. Bozdogan H. Model-selection and Akaike's information criterion (AIC): The general theory and its analytical extensions. Psychometrika 1987, 52:345-370.
7. Bradizza C.M., Stasiewicz P.R., Paas N.D. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: A review. Clinical Psychology Review 2006, 26(2):162-178. 10.1016/j.cpr.2005.11.005.
8. Castel S., Rush B., Urbanoski K., Toneatto T. Overlap of clusters of psychiatric symptoms among clients of a comprehensive addiction treatment service. Psychology of Addictive Behaviors 2006, 20(1):28-35. 10.1037/0893-164X.20.1.28.
9. Chan Y.F., Dennis M.L., Funk R.R. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. Journal of Substance Abuse Treatment 2008, 34(1):14-24. 10.1016/j.jsat.2006.12.031.
10. Collins L.M., Lanza S.T. Latent class and latent transition analysis: With applications in the social, behavioral, and health sciences 2010, Wiley, New York.
11. Compton W.M., Cottler L.B., Jacobs J.L., Ben-Abdallah A., Spitznagel E.L. The role of psychiatric disorders in predicting drug dependence treatment outcomes. The American Journal of Psychiatry 2003, 160(5):890-895.
12. El-Gabalawy R., Tsai J., Harpaz-Rotem I., Hoff R., Sareen J., Pietrzak R.H. Predominant typologies of psychopathology in the United States: A latent class analysis. Journal of Psychiatric Research 2013, 47(11):1649-1657. 10.1016/j.jpsychires.2013.07.028.
13. Flynn P.M., Brown B.S. Co-occurring disorders in substance abuse treatment: Issues and prospects. Journal of Substance Abuse Treatment 2008, 34(1):36-47. 10.1016/j.jsat.2006.11.013.
14. Hosmer D.W., Lemeshow S. Applied logistic regression 1989, Wiley, New York.
15. Jacobi F., Wittchen H.U., Holting C., Hofler M., Pfister H., Muller N., et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: Results from the German Health Interview and Examination Survey (GHS). Psychological Medicine 2004, 34(4):597-611. 10.1017/S0033291703001399.
16. Kelly J.F., Finney J.W., Moos R. Substance use disorder patients who are mandated to treatment: Characteristics, treatment process, and 1- and 5-year outcomes. Journal of Substance Abuse Treatment 2005, 28(3):213-223. 10.1016/j.jsat.2004.10.014.
17. Kendler K.S., Prescott C.A., Myers J., Neale M.C. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Archives of General Psychiatry 2003, 60(9):929-937. 10.1001/archpsyc.60.9.929.
18. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62(6):617-627. 10.1001/archpsyc.62.6.617.
19. Krueger R.F., Markon K.E. Reinterpreting comorbidity: A model-based approach to understanding and classifying psychopathology. Annual Review of Clinical Psychology 2006, 2:111-133. 10.1146/annurev.clinpsy.2.022305.095213.
20. Langas A.M., Malt U.F., Opjordsmoen S. Substance use disorders and comorbid mental disorders in first-time admitted patients from a catchment area. European Addiction Research 2012, 18(1):16-25. 10.1159/000332234.
21. Larsen J.L., Nylund-Gibson K., Cosden M. Using latent class analysis to identify participant typologies in a drug treatment court. Drug and Alcohol Dependence 2014, 138:75-82. 10.1016/j.drugalcdep.2014.02.003.
22. Lazarsfeld P.F., Henry N.W. Latent structure analysis 1968, Houghton Mifflin, Boston.
23. Lin T.H., Dayton C.M. Model selection information criteria for non-nested latent class models. Journal of Educational and Behavioral Statistics 1997, 22:249-264.
24. McCutcheon A.L. Latent class analysis 1987, Sage, Newbury Park, CA.
25. McKay J.R., Weiss R.V. A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups. Preliminary results and methodological issues. Evaluation Review 2001, 25(2):113-161.
26. McLachlan G.J., Peel D. Finite mixture models 2000, Wiley, New York.
27. Menard S. Applied logistic regression analysis 1995, Sage, Thousand Oaks, CA.
28. Merikangas K.R., Herrell R., Swendsen J., Rossler W., Ajdacic-Gross V., Angst J. Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: Results from the Zurich cohort study. Archives of General Psychiatry 2008, 65(1):47-52. 10.1001/archgenpsychiatry.2007.18.
29. Olino T.M., Klein D.N., Farmer R.F., Seeley J.R., Lewinsohn P.M. Examination of the structure of psychopathology using latent class analysis. Comprehensive Psychiatry 2012, 53(4):323-332. 10.1016/j.comppsych.2011.05.008.
30. Pirkola S.P., Isometsa E., Suvisaari J., Aro H., Joukamaa M., Poikolainen K., et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population-Results from the Health 2000 Study. Social Psychiatry and Psychiatric Epidemiology 2005, 40(1):1-10. 10.1007/s00127-005-0848-7.
31. Polcin D.L., Beattie M. Relationship and institutional pressure to enter treatment: Differences by demographics, problem severity, and motivation. Journal of Studies on Alcohol and Drugs 2007, 68(3):428-436.
32. Prados-Torres A., Calderon-Larranaga A., Hancco-Saavedra J., Poblador-Plou B., van den Akker M. Multimorbidity patterns: A systematic review. Journal of Clinical Epidemiology 2014, 67(3):254-266. 10.1016/j.jclinepi.2013.09.021.
33. Richardson W.S., Doster L.M. Comorbidity and multimorbidity need to be placed in the context of a framework of risk, responsiveness, and vulnerability. Journal of Clinical Epidemiology 2014, 67(3):244-246. 10.1016/j.jclinepi.2013.10.020.
34. Rush B., Castel S., Brands B., Toneatto T., Veldhuizen S. Validation and comparison of diagnostic accuracy of four screening tools for mental disorders in people seeking treatment for substance use disorders. Journal of Substance Abuse Treatment 2013, 44(4):375-383. 10.1016/j.jsat.2012.08.221.
35. Rush B., Urbanoski K., Bassani D., Castel S., Wild T.C., Strike C., et al. Prevalence of co-occurring substance use and other mental disorders in the Canadian population. Canadian Journal of Psychiatry 2008, 53(12):800-809.
36. Schwarz G. Estimating the dimension of a model. Annals of Statistics 1978, 6:461-464.
37. Sclove S.L. Application of model-selection criteria to some problems in multivariate analysis. Psychometrika 1987, 52:333-343.
38. Vaidyanathan U., Patrick C.J., Iacono W.G. Patterns of comorbidity among mental disorders: A person-centered approach. Comprehensive Psychiatry 2011, 52(5):527-535. 10.1016/j.comppsych.2010.10.006.
39. Vaidyanathan U., Patrick C.J., Iacono W.G. Examining the overlap between bipolar disorder, nonaffective psychosis, and common mental disorders using latent class analysis. Psychopathology 2012, 45(6):361-365. 10.1159/000337265.
40. Watkins K.E., Hunter S.B., Wenzel S.L., Tu W., Paddock S.M., Griffin A., et al. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. The American Journal of Drug and Alcohol Abuse 2004, 30(4):749-764.
41. Weich S., McBride O., Hussey D., Exeter D., Brugha T., McManus S. Latent class analysis of co-morbidity in the Adult Psychiatric Morbidity Survey in England 2007: Implications for DSM-5 and ICD-11. Psychological Medicine 2011, 41(10):2201-2212. 10.1017/S0033291711000249.
42. Weisner C., Matzger H., Kaskutas L.A. How important is treatment? One-year outcomes of treated and untreated alcohol-dependent individuals. Addiction 2003, 98(7):901-911.
43. Wusthoff L.E., Waal H., Ruud T., Grawe R.W. A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres. BMC Psychiatry 2011, 11:93. 10.1186/1471-244X-11-93.
44. Zimmerman M., Mattia J.I. The Psychiatric Diagnostic Screening Questionnaire: Development, reliability and validity. Comprehensive Psychiatry 2001, 42(3):175-189. 10.1053/comp.2001.23126.
45. Zimmerman M., Mattia J.I. A self-report scale to help make psychiatric diagnoses: The Psychiatric Diagnostic Screening Questionnaire. Archives of General Psychiatry 2001, 58(8):787-794.